Business & EconomyHealth
Moderna Stock Nearly Triples on Cancer Vaccine Trial
Moderna shares surged 177% after its personalized mRNA cancer vaccine met Phase 3 endpoints in melanoma, marking a historic milestone for cancer treatment.
—6 min read
Tag
#Melanoma
6 articles
HealthBusiness
Moderna Surges After mRNA Cancer Treatment Passes Trial
Moderna and Merck announce their mRNA-based cancer vaccine intismeran met key endpoints in a Phase 3 melanoma trial, sending Moderna shares up over 120%.
—6 min read
Science
Contagious Cancer Found in Lake Catfish, Scientists Report
Scientists discover first-ever contagious cancer in fish, a transmissible melanoma spreading among brown bullhead catfish in Lake Memphremagog.
—5 min read
HealthMedical Research
mRNA Cancer Vaccine Slashes Melanoma Recurrence by 49%
Moderna and Merck's mRNA vaccine reduced melanoma recurrence risk by 49% over five years, offering new hope for advanced skin cancer patients.
—4 min read
Health & ScienceTechnology
mRNA Vaccine Cuts Melanoma Recurrence Risk by 49% in Trial
A personalized mRNA cancer vaccine from Moderna and Merck reduced melanoma recurrence risk by 49% over five years, marking a major advance.
—4 min read
HealthMedical Research
mRNA Vaccine Shows Lasting Protection Against Melanoma
A personalized mRNA cancer vaccine combined with Keytruda reduced melanoma recurrence risk by 49% over five years, according to new clinical trial data.
—4 min read